ARTICLE | Clinical News
Reolysin: Phase II start
September 6, 2010 7:00 AM UTC
Next quarter, Oncolytics plans to begin a Phase II trial to evaluate weekly paclitaxel with or without reolysin in up to 150 patients. The study will be sponsored by the National Cancer Institute (NCI...